Concepedia

Publication | Open Access

Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial

110

Citations

41

References

2022

Year

Abstract

Liraglutide, 3 mg, induces weight loss with delay in GES T<sub>1/2</sub> and reduces calorie intake. Slowing GES and variations in GLP1R and TCF7L2 are associated with liraglutide effects in obesity.

References

YearCitations

Page 1